Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migrainePeter J. Goadsby, Charly Gaul, Linda Wietecha et al.|Brain|2019Cited by 275
Once-Daily Treatment With Atomoxetine in Adults With Attention-Deficit/Hyperactivity DisorderJoel Young, Linda Wietecha, Meihua Qiao et al.|Clinical Neuropharmacology|2011Cited by 61
Atomoxetine Once Daily for 24 Weeks in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)Linda Wietecha, Keith E. Saylor, Joel Young et al.|Clinical Neuropharmacology|2012Cited by 22
Atomoxetine Increased Effect over Time in Adults with Attention‐Deficit/Hyperactivity Disorder Treated for up to 6 Months: Pooled Analysis of Two Double‐Blind, Placebo‐Controlled, Randomized TrialsLinda Wietecha, Robert L. Findling, Elias Sarkis et al.|CNS Neuroscience & Therapeutics|2016Cited by 10